Photothermal therapy [Neurosurgery Wiki]

This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong.
====== Photothermal therapy ======


Photothermal therapy refers to efforts to use [[electromagnetic radiation]] for the treatment of various medical conditions, including cancer. This approach is an extension of [[photodynamic therapy]], in which a photosensitizer is excited with specific band light.
----
Zhang et al. developed a photothermal therapy (PTT) based on [[Molybdenum carbide nanosheets]] for [[melanoma treatment]] while utilizing integrated [[metabolomics]] to investigate the metabolic shift of [[metabolome]] combined lipidome during PTT at the molecular level.
The results demonstrated that 1 mg ml-1 Mo2C nanosheets could efficiently convert [[laser]] energy into heat with a strong and stable photothermal effect (74 ± 0.9 °C within 7 cycles). Furthermore, Mo2C-based PTT led to a rapid decrease in melanoma volume (from 3.299 to 0 cm2) on the sixth day, indicating the effective elimination of melanoma. Subsequent integrated metabolomics analysis revealed significant changes in aqueous metabolites (including organic acids, amino acids, fatty acids, and amines) and lipid classes (including phospholipids, lysophospholipids, and sphingolipids), suggesting that melanoma caused substantial fluctuations in both metabolome and [[lipidome]], while Mo2C-based PTT helped improve amino acid metabolism-related biological events (such as tryptophan metabolism) impaired by melanoma. These findings suggest that Mo2C nanosheets hold significant potential as an effective therapeutic agent for skin tumors, such as melanoma. Moreover, through exploring multidimensional bioinformation, integrated metabolomics technology provides novel insights for studying the metabolic effects of tumors, monitoring the correction of metabolic abnormalities by Mo2C nanosheet therapy, and evaluating the therapeutic effect on tumors
((Zhang D, Wang M, Li Y, Liang G, Zheng W, Gui L, Li X, Zhang L, Zeng W, Yang Y, Zeng Y, Huang Z, Fan R, Lu Y, Guan J, Li T, Cheng J, Yang H, Chen L, Zhou J, Gong M. Integrated metabolomics revealed the photothermal therapy of melanoma by Mo2C nanosheets: toward rehabilitated homeostasis in metabolome combined lipidome. J Mater Chem B. 2024 Jan 2. doi: 10.1039/d3tb02123h. Epub ahead of print. PMID: 38165726.)).
----
The second near-infrared (NIR II) type I photosensitizer has the intrinsic advantages in [[photodynamic therapy]]/[[photothermal therapy]] (PDT/PTT) of some malignant tumors (MTs) with deep infiltration, large size, complicated location, and low possibility of surgery/radiotherapy. Herein, three [[chalcogen]]-elements-based donor-acceptor (D-A) type semiconducting polymers (PTS, PTSe, and PTTe) have been synthesized and fully characterized, demonstrating strong absorption in near infrared (NIR) II region. Upon adjusting the chalcogen elements, the intramolecular charge transfer (ICT) characteristics and the heavy atom effect are tuned to enhance the intersystem crossing rate, improving the photodynamic effect. Moreover, the energy levels and Gibbs free energies are tuned to facilitate the type I photodynamic process. As a result, PTTe NPs produce superoxide anion radicals (O2 •- ) more efficiently and demonstrate higher photothermal conversion efficiency than PTS and PTSe NPs upon a NIR II (1064 nm) laser irradiation, exhibiting unprecedented NIR-II type I PDT/PTT performance in vitro and in vivo. This work provides ideas for achieving high performance NIR-II type I PDT/PTT SPs for hypoxic oncotherapy
((Wen K, Tan H, Peng Q, Chen H, Ma H, Wang L, Peng A, Shi Q, Cai X, Huang H. Achieving Efficient NIR-II Type I Photosensitizers for Photodynamic/Photothermal Therapy upon Regulating Chalcogen Elements. Adv Mater. 2021 Dec 21:e2108146. doi: 10.1002/adma.202108146. Epub ahead of print. PMID: 34935224.)).